Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1986 Nov;59(3):411–417.

The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

P Möller, B Lämmler, B Herrmann, H F Otto, G Moldenhauer, F Momburg
PMCID: PMC1453200  PMID: 3491784

Abstract

Eight cases of the recently reported 'primary mediastinal clear cell lymphoma of B-cell type' (Möller et al., 1986) were examined immunohistologically for the expression of cytoplasmic and/or surface antigens of MHC class I and II with mAbs directed against framework determinants of HLA-A,B,C (W6/32; B9.12.1), HLA-DP,DR,DQ (2.06), -DQ (Leu 10; Tü22), -DR (Tü34) gene products, and with mAbs specific for beta 2-microglobulin (BBM-1) and the HLA-D associated invariant chain (Vic-Y1). Besides the reported Ig-deficiency, the neoplastic B-cells of 7/8 tumours have variable defects in MHC antigen expression. Three lack both class I and class II antigens, one tumour lacks class I antigens but expresses HLA-DQ and -DR on the majority of neoplastic cells, three others contain varying proportions of MHC-antigen deficient tumour cells. The expression of Ii is closely correlated with HLA-D(R) expression and its antigenic sites are strictly located in the cytoplasm. Against the background of current knowledge, the variable and occasionally severe defects in MHC antigen expression within the herein presented series of B-cell lymphomas suggest that this unusual feature might be another characteristic of a novel lymphoma type.

Full text

PDF
411

Images in this article

412Figure 1
on p.412
414Figure 2
on p.414
414Figure 2
on p.414
415Figure 3
on p.415
415Figure 4
on p.415

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Accolla R. S., Carra G., Guardiola J. Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5145–5149. doi: 10.1073/pnas.82.15.5145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aglietta M., Piacibello W., Stacchini A., Dezza L., Sanavio F., Malavasi F., Infelise V., Resegotti L., Gavosto F. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors. Cancer Res. 1986 Apr;46(4 Pt 1):1783–1787. [PubMed] [Google Scholar]
  3. Al-Katib A., Koziner B. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression. Br J Haematol. 1984 Jul;57(3):373–382. doi: 10.1111/j.1365-2141.1984.tb02911.x. [DOI] [PubMed] [Google Scholar]
  4. Alexanian R., Barlogie B., Fritsche H. Beta 2 microglobulin in multiple myeloma. Am J Hematol. 1985 Dec;20(4):345–351. doi: 10.1002/ajh.2830200405. [DOI] [PubMed] [Google Scholar]
  5. Alonso M. C., Navarrete C., Solana R., Torres A., Pena J., Festenstein H. Differential expression of HLA-DR and HLA-DQ antigens on normal cells of the myelomonocytic lineage. Tissue Antigens. 1985 Nov;26(5):310–317. doi: 10.1111/j.1399-0039.1985.tb02229.x. [DOI] [PubMed] [Google Scholar]
  6. Anderson K. C., Bates M. P., Slaughenhoupt B. L., Pinkus G. S., Schlossman S. F., Nadler L. M. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984 Jun;63(6):1424–1433. [PubMed] [Google Scholar]
  7. Barcos M., Minowada J., Minato K., Pollard C., Cancino M., Han T., Henderson E., Ozer H. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies. Leuk Res. 1983;7(4):523–537. doi: 10.1016/0145-2126(83)90047-4. [DOI] [PubMed] [Google Scholar]
  8. Berman B., Duncan M. R., Smith B., Ziboh V. A., Palladino M. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells. J Invest Dermatol. 1985 Jan;84(1):54–58. doi: 10.1111/1523-1747.ep12274691. [DOI] [PubMed] [Google Scholar]
  9. Bonagura V. R., Agostino N., Crow M. K., Pernis B. Anti-immunoglobulin stimulation of human B lymphocytes is inhibited by anti-class II major histocompatibility complex antibodies. Cell Immunol. 1985 Dec;96(2):442–447. doi: 10.1016/0008-8749(85)90375-2. [DOI] [PubMed] [Google Scholar]
  10. Brodsky F. M. A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes. Immunogenetics. 1984;19(3):179–194. doi: 10.1007/BF00364762. [DOI] [PubMed] [Google Scholar]
  11. Brodsky F. M., Bodmer W. F., Parham P. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol. 1979 Jul;9(7):536–545. doi: 10.1002/eji.1830090709. [DOI] [PubMed] [Google Scholar]
  12. Clement L. T., Tedder T. F., Gartland G. L. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation. J Immunol. 1986 Apr 1;136(7):2375–2381. [PubMed] [Google Scholar]
  13. Collins T., Lapierre L. A., Fiers W., Strominger J. L., Pober J. S. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci U S A. 1986 Jan;83(2):446–450. doi: 10.1073/pnas.83.2.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Corley R. B., LoCascio N. J., Ovnic M., Haughton G. Two separate functions of class II (Ia) molecules: T-cell stimulation and B-cell excitation. Proc Natl Acad Sci U S A. 1985 Jan;82(2):516–520. doi: 10.1073/pnas.82.2.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Edwards J. A., Jones D. B., Evans P. R., Smith J. L. Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages. Immunology. 1985 Jul;55(3):489–500. [PMC free article] [PubMed] [Google Scholar]
  16. Evans R. L., Engleman E. G. Progress toward understanding self-tolerance. Semin Hematol. 1985 Jan;22(1):68–80. [PubMed] [Google Scholar]
  17. Gregg E. O., Al-Saffar N., Jones D. B., Wright D. H., Stevenson F. K., Smith J. L. Immunoglobulin negative follicle centre cell lymphoma. Br J Cancer. 1984 Dec;50(6):735–744. doi: 10.1038/bjc.1984.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Guy K., Krajewski A. S., Dewar A. E. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Br J Cancer. 1986 Feb;53(2):161–173. doi: 10.1038/bjc.1986.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guy K., Meehan R. R., Dewar A. E., Larhammar D. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Immunology. 1986 Feb;57(2):181–188. [PMC free article] [PubMed] [Google Scholar]
  20. Hokland M., Larsen B., Heron I., Plesner T. Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro. Clin Exp Immunol. 1981 May;44(2):239–246. [PMC free article] [PubMed] [Google Scholar]
  21. Horning S. J., Doggett R. S., Warnke R. A., Dorfman R. F., Cox R. S., Levy R. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood. 1984 May;63(5):1209–1215. [PubMed] [Google Scholar]
  22. Knowles D. M., 2nd, Dodson L., Burke J. S., Wang J. M., Bonetti F., Pelicci P. G., Flug F., Dalla-Favera R., Wang C. Y. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage. Am J Pathol. 1985 Sep;120(3):356–370. [PMC free article] [PubMed] [Google Scholar]
  23. Krajewski A. S., Guy K., Dewar A. E., Cossar D. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas. J Pathol. 1985 Feb;145(2):185–194. doi: 10.1002/path.1711450206. [DOI] [PubMed] [Google Scholar]
  24. Lisowska-Grospierre B., Charron D. J., de Préval C., Durandy A., Griscelli C., Mach B. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J Clin Invest. 1985 Jul;76(1):381–385. doi: 10.1172/JCI111974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Long E. O., Mach B., Accolla R. S. Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family. Immunogenetics. 1984;19(4):349–353. doi: 10.1007/BF00345408. [DOI] [PubMed] [Google Scholar]
  26. Malissen B., Rebai N., Liabeuf A., Mawas C. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur J Immunol. 1982 Sep;12(9):739–747. doi: 10.1002/eji.1830120908. [DOI] [PubMed] [Google Scholar]
  27. Momburg F., Degener T., Bacchus E., Moldenhauer G., Hämmerling G. J., Möller P. Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer. Int J Cancer. 1986 Feb 15;37(2):179–184. doi: 10.1002/ijc.2910370203. [DOI] [PubMed] [Google Scholar]
  28. Momburg F., Koch N., Möller P., Moldenhauer G., Butcher G. W., Hämmerling G. J. Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. J Immunol. 1986 Feb 1;136(3):940–948. [PubMed] [Google Scholar]
  29. Nissen M. H., Plesner T., Larsen J. K., Olesen B. K., Ernst P. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment. Clin Exp Immunol. 1985 Feb;59(2):327–335. [PMC free article] [PubMed] [Google Scholar]
  30. Owen M. J., Kissonerghis A. M., Lodish H. F., Crumpton M. J. Biosynthesis and maturation of HLA-DR antigens in vivo. J Biol Chem. 1981 Sep 10;256(17):8987–8993. [PubMed] [Google Scholar]
  31. Palacios R., Martinez-Maza O., Guy K. Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3456–3460. doi: 10.1073/pnas.80.11.3456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pallesen G., Beverley P. C., Lane E. B., Madsen M., Mason D. Y., Stein H. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies. J Clin Pathol. 1984 Aug;37(8):911–918. doi: 10.1136/jcp.37.8.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Pawelec G. P., Shaw S., Ziegler A., Müller C., Wernet P. Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. J Immunol. 1982 Sep;129(3):1070–1075. [PubMed] [Google Scholar]
  34. Quaranta V., Majdic O., Stingl G., Liszka K., Honigsmann H., Knapp W. A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J Immunol. 1984 Apr;132(4):1900–1905. [PubMed] [Google Scholar]
  35. Rhodes J., Jones D. H., Bleehen N. M. Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo. Clin Exp Immunol. 1983 Sep;53(3):739–743. [PMC free article] [PubMed] [Google Scholar]
  36. Rosa F., Fellous M., Dron M., Tovey M., Revel M. Presence of an abnormal beta 2-microglobulin mRNA in Daudi cells: induction by interferon. Immunogenetics. 1983;17(2):125–131. doi: 10.1007/BF00364752. [DOI] [PubMed] [Google Scholar]
  37. Schuurman R. K., van Rood J. J., Vossen J. M., Schellekens P. T., Feltkamp-Vroom T. M., Doyer E., Gmelig-Meyling F., Visser H. K. Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency. Clin Immunol Immunopathol. 1979 Dec;14(4):418–434. doi: 10.1016/0090-1229(79)90094-1. [DOI] [PubMed] [Google Scholar]
  38. Snyder D. S., Beller D. I., Unanue E. R. Prostaglandins modulate macrophage Ia expression. Nature. 1982 Sep 9;299(5879):163–165. doi: 10.1038/299163a0. [DOI] [PubMed] [Google Scholar]
  39. Sparrow R. L., Williams N. The pattern of HLA-DR and HLA-DQ antigen expression on clonable subpopulations of human myeloid progenitor cells. Blood. 1986 Feb;67(2):379–384. [PubMed] [Google Scholar]
  40. Stashenko P., Nadler L. M., Hardy R., Schlossman S. F. Characterization of a human B lymphocyte-specific antigen. J Immunol. 1980 Oct;125(4):1678–1685. [PubMed] [Google Scholar]
  41. Swerdlow S. H., Murray L. J., Habeshaw J. A., Stansfeld A. G. Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia. Br J Cancer. 1984 Nov;50(5):587–599. doi: 10.1038/bjc.1984.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Trowbridge I. S., Hyman R., Klein G. Human B cell line deficient in the expression of B cell-specific glycoproteins (GP 27,35). Eur J Immunol. 1977 Sep;7(9):640–645. doi: 10.1002/eji.1830070912. [DOI] [PubMed] [Google Scholar]
  43. Trump D. L., Mann R. B. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer. 1982 Jul 15;50(2):277–282. doi: 10.1002/1097-0142(19820715)50:2<277::aid-cncr2820500218>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  44. Wang C. Y., Al-Katib A., Lane C. L., Koziner B., Fu S. M. Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines. J Exp Med. 1983 Nov 1;158(5):1757–1762. doi: 10.1084/jem.158.5.1757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Woda B. A., Racklin B., Rappaport H. Altered expression of histocompatibility antigens on "B" large cell lymphomas. Blood. 1981 Apr;57(4):802–804. [PubMed] [Google Scholar]
  46. Ziegler A., Uchańska-Ziegler B., Zeuthen J., Wernet P. HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays. Somatic Cell Genet. 1982 Nov;8(6):775–789. doi: 10.1007/BF01543018. [DOI] [PubMed] [Google Scholar]
  47. Zinkernagel R. M., Doherty P. C. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 1979;27:51–177. doi: 10.1016/s0065-2776(08)60262-x. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES